# ELEDON PHARMACEUTICALS INC (ELDN)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ELDN/

- Reporting holders: 7
- Reported value: $54.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Everhart Financial Group, Inc.](https://holderbook.com/funds/1852858-everhart-financial-group-inc/) | $25.3K | 10,000 | 0.0% | 3 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $20.2K | 7,987 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $4.3K | 1,709 | 0.0% | 3 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $3.3K | 1,305 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $1.1K | 453 | 0.0% | 3 |
| [Planning Strategies Inc.](https://holderbook.com/funds/2139665-planning-strategies-inc/) | $458 | 181 | 0.0% | 2 |
| [Byrne Asset Management LLC](https://holderbook.com/funds/1911322-byrne-asset-management-llc/) | $2 | 1 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 7 | $54.7K |
| Q2 2026 | 161 | $200.7M |
| Q1 2026 | 124 | $139.6M |
| Q4 2025 | 98 | $72.6M |
| Q3 2025 | 83 | $99.2M |
| Q2 2025 | 85 | $111.2M |
| Q1 2025 | 83 | $130.7M |
| Q4 2024 | 75 | $158.7M |
| Q3 2024 | 34 | $46.0M |
| Q2 2024 | 32 | $49.8M |
| Q1 2024 | 29 | $19.8M |
| Q4 2023 | 28 | $16.5M |

